- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02928900
Patient Actor Training to Improve HIV Services for Adolescents in Kenya (SPEED)
Simulated Patient Encounters to Promote Early Detection and Engagement in HIV Care for Adolescents
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Adolescents and youth have the highest HIV incidence rates compared to any other age strata. Inadequate provision of accessible and acceptable HIV testing, counseling, and treatment services has been cited as a barrier to uptake of and retention in HIV care in this population.
The "SPEED" study aims to develop and evaluate a clinical training intervention utilizing Standardized Patient (SP) actors to improve communication and interpersonal skills of health care workers (HCWs) who work with adolescents and youth (ages 10-24), resulting in increased engagement in HIV care in Kenya. This intervention includes a series of role plays between HCW participants and professional Kenyan actors, followed by feedback and debriefing sessions. The hypothesis is that SP encounters will increase HCW confidence and capacity to facilitate HIV status disclosure and provide supportive interactions with HIV-infected youth, which will in turn increase uptake and improve retention in HIV services among adolescents and youth.
The pilot phase (Aim 1) will consist of developing patient case scripts specific to adolescent HIV-related care and counseling needs and establishing HCW competency scores. To evaluate the intervention, a cluster randomized controlled stepped-wedge trial will be conducted in 24 HIV care and treatment facilities to assess the impact of SP encounters on the proportion of adolescents and youth patients retained in care at HIV treatment facilities in Kenya (Aim 2). Finally, the cost effectiveness and cost utility of the SP intervention will be determined (Aim 3). The estimated study duration is five years.
The primary outcomes from Aim 1 are final scripts and pass/fail scores for use in SP encounters. The primary outcome for the randomized controlled trial (RCT) (Aim 2) is retention in care among HIV-positive adolescents and youth, based on electronic medical records data. Secondary outcomes will include satisfaction (patients and HCWs), HCW competency in youth- friendly counseling, antiretroviral therapy adherence, and viral suppression. For the cost effectiveness and cost utility analyses (Aim 3), the cost per additional HIV-infected adolescent/youth retained in care and the cost per additional life year saved and disability-adjusted life averted will be estimated.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Homa Bay, Kenya
- HIV care facility 6
-
Kiambu, Kenya
- HIV care facility 3
-
Kiambu, Kenya
- HIV care facility 4
-
Kisumu, Kenya
- HIV care facility 5
-
Nairobi, Kenya
- HIV care facility 1
-
Nairobi, Kenya
- HIV care facility 2
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria: Listed by population
Facilities:
- HIV care and treatment facilities in Kenya with ≥40 adolescents currently in HIV care
- EMR data systems
- No concurrent adolescent interventions
Adolescent patient records:
- Records of adolescents and youth ages 10-24
- Enrollment in HIV care and treatment at one of the study facilities
Adolescent satisfaction surveys:
- Patients ages 10-24 seeking counseling or treatment services at trial site who are HIV-infected
- Willing and able to provide informed consent or assent based on age and presence of a caregiver.
- Reside in Kenya
Health care workers:
- >18 years of age
- Employed at trial site in clinical care for at least three months and/or have a 1 year contract (i.e. not temporary staff)
- Provide clinical services to adolescents
- Reside in Kenya
Exclusion Criteria:
Facilities:
- If inclusion criteria are not met
- If anything would prevent the complete conduct of the training intervention at that site and/or the collection of outcome measures
Adolescents and health care worker surveys:
• If an individual has conditions that would place them at increased risk or preclude the individual's full compliance with or completion of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention period
In this stepped-wedge trial design, the experimental arm refers to the time period when the study sites receive the clinician training intervention.
The intervention is a clinician training using standardized patient actors to improve communication and empathy skills of health care providers who serve HIV-positive adolescents and youth.
|
This intervention is a clinician training using SP actors to improve communication and empathy skills of HIV care providers who serve HIV-positive adolescents and youth in Kenya.
|
|
No Intervention: Control period
In this stepped-wedge trial design, the no intervention arm refers to the time period before the study sites receive the clinician training intervention, during which standard of care is provided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention in HIV Care
Time Frame: Up to four years after baseline
|
The primary outcome is change in retention in HIV care between the intervention and control periods, where retention is defined as return for first follow-up visit within 3 months among newly enrolled adolescent clients OR follow-up visit after 're-engagement visit' (after lost-to-follow-up for >90 days since last visit, with no record of death or transfer).
|
Up to four years after baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of HCWs With Pass/Fail Scores
Time Frame: Up to one month after last day of training
|
The proportion of HCW participants who achieved competency upon completion of the training.
|
Up to one month after last day of training
|
|
Numeric Scores From SP Actors
Time Frame: Up to one week after last day of training
|
All SP actors will complete a check-list to provide non-technical feedback to each HCW participant.
Scores will be used to compute the overall pass/fail score at completion of the training.
|
Up to one week after last day of training
|
|
Health Care Worker Competency
Time Frame: Baseline and every nine months for up to four years
|
This outcome is measured as change in mean competency score between intervention and control periods using a structured survey.
|
Baseline and every nine months for up to four years
|
|
Health Care Workers' Satisfaction With Skills
Time Frame: Baseline and every nine months for up to four years
|
This outcome is measured as change in mean satisfaction scores between intervention (post-training) and control periods (pre-training), using a structured survey.
These surveys will be conducted at baseline, and every nine months at the end of the training in each wave.
Exit interviews among trained participants will be conducted about one year after each training wave for up to four waves to complement the quantitative results.
|
Baseline and every nine months for up to four years
|
|
Adolescent Patients' Satisfaction With Care
Time Frame: Baseline and every nine months for up to four years
|
This outcome is defined as mean change in satisfaction score between intervention and control periods, using a structured survey.
|
Baseline and every nine months for up to four years
|
|
Retention in HIV Care (Secondary)
Time Frame: Baseline and every nine months for up to four years
|
A secondary measure of retention in HIV care is return for any follow-up visit within 3 months (90 days) among currently enrolled HIV-positive adolescent patients
|
Baseline and every nine months for up to four years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Antiretroviral (ART) Adherence in HIV-positive Adolescents
Time Frame: Baseline and every nine months for up to four years
|
This measure is defined as change in the proportion of visits with ART refills within 1 week of scheduled visit between intervention and control periods using available electronic medical record (EMR) data.
|
Baseline and every nine months for up to four years
|
|
Viral Load in HIV-positive Adolescents
Time Frame: Baseline and every nine months for up to four years
|
This measure is defined as change in viral load between intervention and control periods using available EMR data.
|
Baseline and every nine months for up to four years
|
|
Linkage to Adolescent Friendly Services in HIV-positive Adolescents
Time Frame: Baseline and every nine months for up to four years
|
This measure is defined as change in the proportion of visits with referrals to affiliated services (e.g.
family planning) between intervention and control periods using available EMR data.
|
Baseline and every nine months for up to four years
|
|
AIDS Defining Illness in HIV-positive Adolescents
Time Frame: Baseline and every nine months for up to four years
|
This measure is defined as change in the proportion of visits with any AIDS defining illness between intervention and control periods using available EMR data.
|
Baseline and every nine months for up to four years
|
|
Mortality in HIV-positive Adolescents
Time Frame: Baseline and every nine months for up to four years
|
This measure is defined as change in the proportion of deaths between intervention and control periods using available EMR data.
|
Baseline and every nine months for up to four years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Pamela Kohler, PhD, MPH, RN, University of Washington
- Study Director: Dalton Wamalwa, MMed, MPH, University of Nairobi
Publications and helpful links
General Publications
- Wilson K, Onyango A, Mugo C, Guthrie B, Slyker J, Richardson B, John-Stewart G, Inwani I, Bukusi D, Wamalwa D, Kohler P. Kenyan HIV Clinics With Youth-Friendly Services and Trained Providers Have a Higher Prevalence of Viral Suppression Among Adolescents and Young Adults: Results From an Observational Study. J Assoc Nurses AIDS Care. 2022 Jan-Feb 01;33(1):45-53. doi: 10.1097/JNC.0000000000000302.
- Wilson KS, Mugo C, Bukusi D, Inwani I, Wagner AD, Moraa H, Owens T, Babigumira JB, Richardson BA, John-Stewart GC, Slyker JA, Wamalwa DC, Kohler PK. Simulated patient encounters to improve adolescent retention in HIV care in Kenya: study protocol of a stepped-wedge randomized controlled trial. Trials. 2017 Dec 28;18(1):619. doi: 10.1186/s13063-017-2266-z.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Blood-Borne Infections
- Urogenital Diseases
- Genital Diseases
- Immune System Diseases
- Infections
- RNA Virus Infections
- Virus Diseases
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- STUDY00002035
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV/AIDS
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of Massachusetts, BostonCompleted
-
Stanford UniversityJanssen Services, LLCCompleted
-
ViiV HealthcareJohns Hopkins University; Pfizer; Vanderbilt University; University of North Carolina...Completed
-
Massachusetts General HospitalNational Institute of Allergy and Infectious Diseases (NIAID); Emory University and other collaboratorsCompletedHIV | AIDSUganda, South Africa
-
University of California, San DiegoCompleted
-
University of California, San DiegoJanssen Research & Development, LLCCompleted
-
Elizabeth Glaser Pediatric AIDS FoundationPopulation Council; Ministry of Health, TanzaniaCompleted
-
Medical College of WisconsinNational Institute of Mental Health (NIMH)CompletedHIV | AIDSUnited States, Russian Federation
Clinical Trials on Clinician training intervention
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
VA Office of Research and DevelopmentRecruitingLow Back Pain | Informal Caregivers | BiomechanicsUnited States
-
University of WashingtonNational Institute on Aging (NIA)CompletedLiver Cirrhosis | Lung Neoplasms | Neoplasm Metastasis | Pulmonary Disease, Chronic Obstructive | Dementia | Kidney Failure, Chronic | Chronic Disease | Peripheral Vascular Disease | Lung Diseases, Interstitial | Heart Failure, Congestive | Diabetes With End Organ InjuryUnited States
-
University of WashingtonNational Institute on Aging (NIA)CompletedLiver Cirrhosis | Neoplasm Metastasis | Pulmonary Disease, Chronic Obstructive | Dementia | Kidney Failure, Chronic | Chronic Disease | Peripheral Vascular Disease | Lung Diseases, Interstitial | Lung Neoplasm | Heart Failure,Congestive | Diabetes With End Organ InjuryUnited States
-
Duke UniversityCompleted
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingType 2 Myocardial InfarctionUnited States
-
Fenway Community HealthPatient-Centered Outcomes Research Institute; Kaiser Permanente; Howard Brown... and other collaboratorsCompletedEducation | Gender Identity | Sexual Orientation | LGBT Health | Cultural CompetencyUnited States
-
Ontario Shores Centre for Mental Health SciencesUS Department of Veterans AffairsCompletedPostTraumatic Stress Disorder
-
Duke UniversityUniversity of PittsburghActive, not recruitingSmoking Cessation | Pregnancy | Communication ResearchUnited States
-
VA Office of Research and DevelopmentEnrolling by invitationHeart Failure | Cancer | Chronic Obstructive Pulmonary Disease | Dementia | Interstitial Lung Disease | End-stage Renal Disease | Seriously Ill Patients | End-stage Liver DiseaseUnited States